Quantcast

Latest Heparins Stories

2014-09-10 08:29:40

Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectual property rights relating to Arixtra® (fondaparinux sodium) Injection and the authorized generic (AG) of Arixtra from Aspen Global Incorporated. Arixtra...

2014-07-30 08:32:18

LifeScienceIndustryResearch.com adds Latest Reports on Heparin sodium and calcium Industry to its store. DALLAS, July 30, 2014 /PRNewswire-iReach/ -- This is a professional and in-depth market survey on Global and Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The report firstly reviews the basic information of Heparin sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including its classification, application and manufacturing technology. The...

2014-07-07 09:40:29

The Lancet A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment. The study suggests that use of one of the drugs, heparin, could result in improved outcomes (such as a reduced rate of repeat heart attacks), compared to the other drug tested, bivalirudin, which is in widespread use in high-income countries, and is around 400 times more expensive than heparin. The results of the HEAT-PPCI trial...

2014-06-23 08:23:14

DUBLIN, June 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hh5qrs/global_market) has announced the addition of the "Global Market Report of Heparin sodium (CAS 9041-08-1)" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769Global Market Report of Heparin sodium (CAS 9041-08-1) aims at providing comprehensive data on Heparin sodium globally and regionally (Europe, Asia, North America, Latin America etc.). It captures...

2014-06-18 12:16:58

University of Pennsylvania School of Medicine Adding thrombolysis drugs to conventional therapy may offer significant benefits in select patients Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent...

2014-05-22 08:28:45

Seven-fold lower incidence of VTEs in patients treated with ISIS-FXIRx compared to enoxaparin CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated with ISIS-FXI(Rx) undergoing total knee replacement surgery, or total knee arthroplasty (TKA). ISIS-FXI(Rx) inhibits the production of Factor...

2014-05-13 12:27:29

IPRO-designed "MAP" Tool Addresses How to Handle Numerous Patient Situations, In Order to Reduce Risk of Both Excessive Bleeding and Formation of Blood Clots LAKE SUCCESS, N.Y., May 13, 2014 /PRNewswire-USNewswire/ -- A new, free-of-charge tool designed by the Peri-Procedural Task Force of the IPRO-led New York State Anticoagulation Coalition will enable clinicians to more easily determine how, whether and when to stop the use of warfarin and other anticoagulants prior to surgery and...

2014-05-06 08:33:03

ALBANY, New York, May 6, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Disposable Gloves Market For Medical and Non-Medical (Food, Cleanroom, Industrial And Other) Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019" to its large collection of research report. The global market for disposable gloves is primarily driven by the growing healthcare industry and increasing awareness of hygiene among patients as...

2014-04-28 16:29:07

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antithrombotic Drugs: World Market 2013-2023 http://www.reportbuyer.com/pharma_healthcare/therapeutic/antithrombotic_drugs_world_market.html Report DetailsAntithrombotic agents - discover technological and commercial prospectsWhat does the future hold for treating conditions associated with thrombosis? Visiongain's updated report gives you forecasted revenues to 2023, explaining R&D...

2014-04-15 16:26:48

DUBLIN, April 15, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/4xgpn8/research_and) has announced the addition of the "Research and Development Forecast of China Heparin Industry to 2017" [http://www.researchandmarkets.com/research/4xgpn8/research_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Research and Development Forecast of China Heparin Industry to 2017 mainly analyzes...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related